Table 2 Comparison of outcomes between the DAPT and argatroban groups

mRS score of 0–1 at 90 days, no. (%)

80(47.6)

101(74.2)

<0.001

END, no. (%)

37(22.0)

10(7.4)

<0.001

Extracerebral bleeding, no. (%)

2(1.1)

3(2.2)

0.48

Total NIHSS score at discharge, Median (IQR)

3(2–6)

2(2–4)

0.04

Motor NIHSS at discharge, Median (IQR)

3(1–5)

2(1–3)

0.03

Sense NIHSS at discharge, Median (IQR)

1(1–2)

1(1–3)

0.57

Ataxia NIHSS at discharge, Median (IQR)

1(1–2)

1(1–2)

0.42

Hospitalization days, mean (SD), d

8.5 ± 1.9

8.0 ± 1.3

0.015

Venous thrombosis, no. (%)

18(10.7%)

8(5.8%)

0.13

APTT at 24 h, mean (SD), s

22.6 ± 3.1

41.5 ± 3.2

<0.001